Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan · Delayed Price · Currency is JPY 7,240.00
+17.00 (0.24%)
Oct 21, 2026, 3:30 PM JST
Kobayashi Pharmaceutical Market Cap
Kobayashi Pharmaceutical has a market cap or net worth of 538.21 billion as of October 20, 2026. It is the 4,758th most valuable company in the world and the 349th biggest in Japan. Its market cap has increased by 37.96% in one year.
Market Cap
538.21B
Enterprise Value
481.62B
Revenue
167.47B
Global Rank
Country Rank
#349 Japan
PE Ratio
330.43
ChartMarket Cap Chart
Since August 17, 1999, Kobayashi Pharmaceutical's market cap has increased from 245.70B to 538.21B, an increase of 119.05%. That is a compound annual growth rate of 2.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 538.21B | 33.38% |
| Dec 30, 2025 | 403.51B | -12.87% |
| Dec 30, 2024 | 463.13B | -8.08% |
| Dec 29, 2023 | 503.84B | -22.52% |
| Dec 30, 2022 | 650.29B | -7.68% |
| Dec 30, 2021 | 704.43B | -28.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Unicharm | 1.73T |
| Shiseido Company | 1.40T |
| Rohto Pharmaceutical | 665.80B |
| Lion Corporation | 521.17B |
| MTG Co., Ltd. | 340.21B |
| KOSE Holdings | 336.53B |
| Pola Orbis Holdings | 316.99B |
| Pigeon | 260.41B |